Heparin and protease inhibitors in the prevention of experimental acute pancreatic necrosis in dogs.
D000135:Acid Phosphatase / Q000378:metabolism; D000208:Acute Disease; D000614:Aminocaproates / Q000627:therapeutic use*; D000681:Amylases / Q000097:blood; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D004285:Dogs; D005340:Fibrinogen; D006493:Heparin / Q000627:therapeutic use*; D008247:Lysosomes; D009336:Necrosis; D010179:Pancreas / Q000201:enzymology; D010195:Pancreatitis / Q000517:prevention & control*; D011480:Protease Inhibitors
D000614:Aminocaproates; D011480:Protease Inhibitors; D005340:Fibrinogen; D006493:Heparin; D007611:Aprotinin; D000135:Acid Phosphatase; D000681:Amylases